All 4 tracked stories fall under one category: pharma. They are better corroborated than the beat average, carrying 20.5 original sources each against 3.9 for the same window. AOL is the most frequent co-covered peer, appearing in 1 of the 4 tracked stories.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Food and Drug Administration (FDA)
All 4 tracked stories fall under one category: pharma. They are better corroborated than the beat average, carrying 20.5 original sources each against 3.9 for the same window. AOL is the most frequent co-covered peer, appearing in 1 of the 4 tracked stories. Across a 130-day span, the pace is roughly 0.2 stories per week. Their average consequence score of 6.3 runs above the beat's 6.2 for that window. We currently track 4 Biotech stories that mention Food and Drug Administration (FDA), published between March 8, 2026 and July 15, 2026.
Stories tracked
4
Per week
0.2
Sources per story
20.5
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 370 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Food and Drug Administration (FDA). Shared-story counts are live from our verified record — not editorial picks.
The CDC's health alert on a cyclosporiasis outbreak with 5,100 suspected cases presents urgent needs in the biotech sector for rapid diagnostics, antiparasitic drug development, and food safety technologies. The parasite Cyclospora cayetanensis, with its long incubation period, challenges traditional detection methods, while treatment relies on a decades-old antibiotic. Innovators could capitalize on multiplex PCR panels and next-generation sequencing for outbreak tracking.
The sudden closure of a primary peptide supplier has sent shockwaves through the biotech research community, significantly reducing the availability of high-purity compounds. Nova Life Peptides warns that this contraction will likely lead to increased costs and delayed timelines for preclinical studies.
The pharmaceutical industry faces renewed scrutiny over direct-to-consumer (DTC) advertising, a practice unique to the U.S. and New Zealand. As healthcare costs rise, regulators are weighing the educational benefits of these ads against their role in driving up prescription volumes and drug prices.
The pharmaceutical industry is undergoing a paradigm shift as regulatory changes and technological breakthroughs reduce reliance on animal models. With the FDA Modernization Act 2.0 paving the way, human-on-a-chip and AI-driven simulations are emerging as more predictive alternatives for drug safety and efficacy.
Food and Drug Administration (FDA) is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
